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Immanuel CN, Teng B, Dong B, Gordon EM, Kennedy JA,
Luellen C, Schwingshackl A, Cormier SA, Fitzpatrick EA, Waters
CM. Apoptosis signal-regulating kinase-1 promotes inflammasome
priming in macrophages. Am J Physiol Lung Cell Mol Physiol 316:
L418–L427, 2019. First published January 10, 2019; doi:10.1152/aj-
plung.00199.2018.—We previously showed that mice deficient in apo-
ptosis signal-regulating kinase-1 (ASK1) were partially protected against
ventilator-induced lung injury. Because ASK1 can promote both cell
death and inflammation, we hypothesized that ASK1 activation regulates
inflammasome-mediated inflammation. Mice deficient in ASK1 expres-
sion (ASK1/) exhibited significantly less inflammation and lung injury
(as measured by neutrophil infiltration, IL-6, and IL-1) in response to
treatment with inhaled lipopolysaccharide (LPS) compared with wild-
type (WT) mice. To determine whether this proinflammatory response
was mediated by ASK1, we investigated inflammasome-mediated re-
sponses to LPS in primary macrophages and bone marrow-derived
macrophages (BMDMs) from WT and ASK1/ mice, as well as the
mouse alveolar macrophage cell line MH-S. Cells were treated with LPS
alone for priming or LPS followed by ATP for activation. When mac-
rophages were stimulated with LPS followed by ATP to activate the
inflammasome, we found a significant increase in secreted IL-1 from
WT cells compared with ASK1-deficient cells. LPS priming stimulated
an increase in NOD-like receptor 3 (NLRP3) and pro-IL-1 in WT
BMDMs, but expression of NLRP3 was significantly decreased in
ASK1/ BMDMs. Subsequent ATP treatment stimulated an increase in
cleaved caspase-1 and IL-1 in WT BMDMs compared with ASK1/
BMDMs. Similarly, treatment of MH-S cells with LPS  ATP caused an
increase in both cleaved caspase-1 and IL-1 that was diminished by the
ASK-1 inhibitor NQDI1. These results demonstrate, for the first time, that
ASK1 promotes inflammasome priming.
acute respiratory distress syndrome; apoptosis signal regulating ki-
nase-1; LPS priming; lung inflammation
INTRODUCTION
Acute respiratory distress syndrome (ARDS) remains a
tragic illness with high morbidity and mortality (6, 11, 24, 32,
42, 46). Although mortality associated with ARDS has de-
creased, it still remains high at ~40% (32). Interleukin-1
(IL-1) is an inflammatory mediator produced by macrophages
and known to be chemotactic for neutrophils and to stimulate
proliferation of fibroblasts (16, 45). Previous studies have
shown a correlation between increased IL-1 in the bronchoal-
veolar lavage fluid (BALF) of patients with ARDS and those at
high risk of developing ARDS compared with BALF from
healthy individuals (2, 17, 24, 42, 45). The increase in IL-1,
IL-6, and other inflammatory mediators has been shown to
occur early in the progression of ARDS, with concomitant
IL-1 receptor antagonists implicating it as important early in
the inflammatory insult (39).
Activation of pattern recognition receptors (PRRs) results in
gene expression of numerous inflammatory mediators in alve-
olar macrophages and other immune cells. Recent studies have
focused on the role of an intracellular PRR, NOD-like receptor
3 (NLRP3), in acute lung injury (ALI) and ARDS (5, 12, 18,
27, 28). NLRP3 is one component of the inflammasome, which
also consists of the adaptor molecular apoptosis-associated
speck-like protein containing a CARD (ASC) and caspase-1 (3,
5, 23, 30). Following recognition of its ligand, NLRP3 asso-
ciates with ASC and procaspase-1, resulting in activation of
caspase-1. Caspase-1 has many substrates, including pro-IL-
1, which when cleaved to its biologically active form plays a
critical role in ARDS. Because of the potential for proinflam-
matory-associated tissue damage, IL-1 production is highly
regulated. The canonical pathway of IL-1 production requires
the following two steps: 1) priming [production of the nonac-
tive precursor (pro-IL-1)], followed by 2) activation (NLRP3
inflammasome scaffold formation and subsequent cleavage of
caspase-1, resulting in active caspase-1 and proteolytic cleav-
age of pro-IL-1 in its bioactive form) (22, 40, 44, 49, 52). The
expression of NLRP3 and pro-IL-1 can be induced by Toll-
like receptors (TLRs) via the NF-B signaling pathway. Al-
though some progress has been made in understanding how the
NLRP3 inflammasome is regulated, there are still large gaps in
our understanding of this.
Previous studies have suggested a role for apoptosis signal-
regulating kinase-1 (ASK1) in ventilator-induced lung injury
(VILI) (34), hyperoxia-induced lung injury, production of
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IL-1 and TNF- (8), and lipopolysaccharide (LPS)-induced
septic shock in mice (31). Other studies have suggested that
ASK1 is an intermediate signal in TLR-associated innate
immune responses (53, 54). However, there have been no
studies investigating the role of ASK1 in NLRP3 inflam-
masome activation. We hypothesized that the ASK1 pathway
promotes assembly and activation of the NLRP3 inflam-
masome in alveolar macrophages in ALI, leading to an in-
crease in IL-1 secretion. Using an LPS model in both mice
and cultured cells, we found that deficiency or inhibition of
ASK1 significantly reduced markers of lung injury and
NLRP3-mediated inflammation.
MATERIALS AND METHODS
Mice. The Institutional Animal Care and Use Committee for both
the University of Tennessee Health Science Center and the University
of Kentucky approved all animal procedures. ASK1 knockout mice
(ASK1/, kindly provided by H. Ichijo, University of Tokyo) and
C57BL/6N mice (Harlan, Indianapolis, IN) were used to isolate bone
marrow cells and bronchoalveolar lavage fluid cells. The ASK1
knockout mice were derived from the C57BL/6J strain. Mice (male
and female) ages 10–16 wk were used in all experiments.
In vivo LPS stimulation. We exposed mice to normal saline nebu-
lization (vehicle)  LPS (5 mg/ml for 15 min). After 3, 6, or 24 h, the
mice were anesthetized with intraperitoneal ketamine (80 mg/kg) and
xylazine (15 mg/kg), and a tracheostomy was performed using an
18-gauge catheter. Quasistatic lung compliance was measured from
pressure-volume loops using the flexiVent (SCIREQ, Montreal, QC,
Canada), and BALF was collected using 2  0.7 ml PBS. One aliquot
of cells was counted using a hemocytometer, and a separate aliquot
was cytospun on a glass slide. The hemocytometer counts were used
to quantify macrophages and neutrophils based on size and morphol-
ogy. In addition, the cytospun slides were stained, and then a differ-
ential cell count was performed based on the size, morphology, and
staining of the cells to confirm the percentage of macrophages and
neutrophils. Negligible lymphocytes and eosinophils were counted. At
least 100 were counted for each differential measurement. The lungs
were then retrograde perfused with 10–20 ml PBS, and lung tissue
was collected for histology.
Isolation of macrophages. Macrophages were isolated by consec-
utive bronchoalveolar lavage as previously described (7, 43, 52, 55)
with some minor modifications indicated below. Mice were anesthe-
tized by an intraperitoneal injection of ketamine-xylazine (80 mg/
kg-15 mg/kg). A tracheostomy was performed as described above.
Eight consecutive BALF of sterile Mg2- and Ca2-free PBS with 2
mM EDTA with 0.7 ml/lavage were performed per animal. BALF was
centrifuged at 400 g for 5 min. Cell pellets were suspended in 5 ml of
R10-DMEM. The total number of cells in the suspension was counted
using a hemocytometer, and aliquots of 0.4–0.8  106 cells were
seeded in 12-well plates and allowed to adhere for 2 h. We examined
aliquots of cells before adhesion by anti-F4/80 immunofluorescence
and found that 	98% of the cells were macrophages (data not shown).
Isolation of bone marrow-derived macrophages. Bone marrow-
derived macrophages (BMDMs) were isolated and differentiated as
previously described (55), with some minor modifications indicated
below. Postmortem, bilateral femurs and tibias were harvested, and
bone marrow was isolated by centrifugation at 10,000 g for 15 s,
resuspended in fetal bovine serum containing DMSO, and frozen at
80°C until used. At the start of each experiment, bone marrow cells
were thawed quickly at 37°C and placed in 10 ml of BMDM growth
medium (R10 medium supplemented with 20% L-929-conditioned
media, as a source of macrophage-colony-stimulating factor) in
100-mm petri dishes. On day 4, 8 ml of fresh BMDM growth media
were added, and the cells were allowed to differentiate for 3 additional
days, at which time essentially 100% of the cells were macrophages
(55). Following 7 days in culture, nonadherent cells were removed,
and the remaining cells were washed with 1 PBS before being lifted
from the petri dishes with cell stripper (Corning CellStripper Disso-
ciation reagent). Cells were counted, spun down at 1,500 rpm for 10
min, and resuspended in BMDM growth media before being placed in
12-well culture dishes at a cell density of 4.0  105 to 5.0  105. Cells
were given 24 h to adhere before each experiment. We examined cell
morphology at this stage using a Diff-Quik stain following a cytospin,
and we separately examined anti-F4/80 immunofluorescence and
found that 	98% of the cells were macrophages (data not shown).
ASK1 inhibitor, NQDI1, in BMDMs and MH-S cells. MH-S cells
(Sigma-Aldrich) were pretreated for 1 h with or without the ASK1
inhibitor NQDI1 (2 
M; Sigma-Aldrich) before LPS  ATP treat-
ment. The Ki for NQDI1 was reported to be 500 nM (50). BMDMs
were plated in 12-well culture dishes at a cell density of 5.0  105 and
allowed to adhere for 24 h. The next day, medium was removed, and
the following conditions were applied to the cells: 1) media  vehicle
for 1 h and then media  vehicle for 30 min; 2) LPS (1 
g/ml) 
vehicle for 1 h and then ATP (5 mM)  vehicle for 30 min; 3) NQDI1
(2 
M) for 1 h and then LPS  NQDI1 for 1 h followed by ATP 
NQDI1 for 30 min; 4) LPS  vehicle for 1 h and then ATP  NQDI1
for 30 min; and 5) NQDI1 for 1 h and then LPS  vehicle for 1 h
followed by ATP  vehicle for 30 min. Supernatants were collected
at each time point, centrifuged at 3,000 g for 5 min to remove any
cellular debris, and then stored at 80°C. Cell lysates were collected
after the last time point for each condition, sonicated for 30 s, and then
stored at 80°C.
In vitro LPS stimulation. Cells were treated either with LPS (1

g/ml, 055:B5; Sigma) for 2, 4, or 6 h for priming studies, or for 1 h
of LPS (1 
g/ml), followed by 30 min of ATP (5 mM) for activation
studies. Nigericin-stimulated MH-S cells and BMDMs were used as a
positive control for caspase-1 activation. Supernatant was collected,
centrifuged at 1,000 g for 10 min at 4°C, separated into aliquots in 450

l, and stored at 80°C. Cell lysates were collected with Laemmli
1 SDS sample buffer (Bio-Rad), sonicated for 30 s, and stored at
20°C.
Western blot analysis. After being boiled at 80°C, cell lysates were
separated using SDS gel electrophoresis and then transferred to 0.2

m polyvinylidene difluoride membranes. These membranes were
blocked in 1% TBS-casein with 0.1% Tween or 5% milk and then
incubated with anti-IL-1 (1:1,000, no. 46812507; Cell Signaling),
anti-NLRP3 [1:1,000, D4D8T/46815101 (Cell Signaling) and 1:250,
25N10E9 (Thermo Scientific)], and anti-caspase-1p20 (1:1,000,
1055042/AG-20B-0042-C100; Adipogen) antibodies. The mem-
branes were washed with Tris-buffered saline-Tween 20, incubated
with species-specific horseradish peroxidase-conjugated secondary
antibody (1:2,000), and visualized with Luminatea Forte Western
horseradish peroxidase substrate. Band densitometry measurements to
determine relative quantities of protein were performed using ImageJ
1.42 software for Windows (https://imagej.nih.gov/ij).
ELISA. IL-1 was measured in the cell supernatant and BALF
using species-specific ELISA kits as per the manufacturer’s instruc-
tions [BD559603 (BD Biosciences) and DY401 (R&D Systems)].
Additionally, IL-6 was measured in BALF using a species-specific
ELISA kit as per the manufacturer’s instructions (BD555240; BD
Biosciences). For data analysis, a curve fit was applied to the stan-
dards, and the sample concentrations were extrapolated from the
standard curve using four-parameter logistic software.
Statistical analysis. Statistical analysis was performed with Sigma-
Plot (Jandel Scientific) and GraphPad Prism (GraphPad Software, La
Jolla, CA). Comparison of variables between two groups was per-
formed using a two-way ANOVA, normality and equal variance tests
with Shapiro-Wilk, and pairwise multiple comparison using Holm-
Sidak methods. P values 0.05 were considered significant. Unless
otherwise stated, data were plotted as means  SE, and significant
differences are indicated.
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RESULTS
ASK1 deficiency abrogated LPS-induced lung injury. To
investigate the role of ASK1 in lung inflammation, mice were
treated with aerosolized LPS for 15 min, and responses were
measured 3, 6, and 24 h later. As shown in Fig. 1, LPS
treatment caused increased inflammation, neutrophil accumu-
lation, and protein in the BALF of wild-type (WT) mice as
indicated by histology and BALF protein measurements. In
addition, lung compliance was significantly decreased 3, 6, and
24 h after LPS treatment in WT mice (Fig. 1B). ASK1/ mice
exhibited decreased infiltration of immune cells in lung tissue,





























































Fig. 1. Apoptosis signal-regulating kinase-1 (ASK1) deficiency abrogated lipopolysaccharide (LPS)-induced lung injury. Wild-type (WT) and ASK1-deficient
(ASK1/) mice were either unexposed [time (t)  0 h] or exposed to nebulized LPS in normal saline for 15 min, and measurements of lung compliance were made
at the indicated times, followed by collection of bronchoalveolar lavage (BAL) fluid and tissue for histology. A: representative hematoxylin- and eosin-stained lung
sections 6 h after exposure to saline or LPS indicating increased inflammation following LPS treatment in WT mice. B: quasistatic lung compliance was measured in
WT and ASK1/ mice using the flexiVent, demonstrating a significant reduction in WT mice following LPS exposure (n  4–7 mice/group). #Significant difference
from untreated (t  0 h) mice (P  0.05). C: LPS treatment caused increased protein in the BAL fluid (n  4–6). #Significant difference from t  0 h mice (P  0.05).
There were no significant differences in compliance or protein between WT and ASK1/ mice at any of the time points.
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from WT mice. Protein leak in the BALF did not appear to be
abrogated by ASK1 deficiency, since there were no significant
differences between WT and ASK1/ mice (Fig. 1C). LPS
treatment also stimulated an increase in macrophages and
neutrophils in the BALF in WT mice, but these changes were
significantly reduced in ASK1/ mice (Fig. 2). Macrophage
accumulation in BALF was reduced at 24 h in ASK1/ mice,
whereas neutrophil infiltration was decreased at 6 and 24 h.
LPS treatment stimulated a rapid increase in both IL-1 and
IL-6 in BALF in WT and ASK1/ mice, but cytokine levels
decreased by 24 h. There was a significant decrease in IL-1 in
the BALF of ASK1/ mice at the earliest measurement time
after LPS (3 h), whereas IL-6 was reduced at 6 and 24 h.
ASK1 deficiency decreased inflammasome activation in pri-
mary macrophages. Because we observed reduced IL-1, IL-6,
and neutrophil recruitment in the ASK1/ mice similar to
what was previously reported by Kuipers et al. (20) using
NLRP3 knockout mice in a mechanical ventilation-induced
lung injury model, we investigated whether ASK1 deficiency
affected NLRP3 inflammasome activation. Stimulation of pri-
mary macrophages from WT mice with LPS followed by ATP
(to activate the inflammasome) resulted in a significant in-
crease in secreted IL-1 compared with unstimulated macro-
phages or macrophages treated with LPS alone (Fig. 3A).
Consistent with the 3-h results from mice exposed to LPS, the
amount of IL-1 secreted from ASK1/ macrophages in
response to LPS  ATP was significantly less than that
released by WT macrophages. Because the number of macro-
phages recovered from BALF is limited, we continued exper-
iments examining the response to LPS  ATP in BMDMs. As
shown in Fig. 3B, unstimulated BMDMs secreted negligible
IL-1, but LPS  ATP stimulated significant IL-1 release
from WT cells. ASK1-deficient BMDMs secreted significantly














































































































Fig. 2. Lipopolysaccharide (LPS)-induced bronchoalveolar lavage (BAL) fluid cell counts and cytokines were reduced in apoptosis signal-regulating kinase-1
(ASK1)-deficient (ASK1/) mice. Aerosolized LPS induced inflammatory cytokine secretion and cell recruitment in wild-type (WT) mice, but these effects
were decreased in ASK1/ mice. BAL fluid was collected from mice at the indicated times following exposure to LPS, and macrophages (A) and neutrophils
(B) were quantified via microscopy. C and D: IL-1 (C) and IL-6 (D) were measured in the BAL fluid using ELISAs (BD Biosciences). *Significant difference
from WT (P  0.05; n  4–5 in A, 4–6 in B, 3–6 in C, and 4–6 in D).
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of ASK1 would diminish IL-1 secretion, we treated BMDMs
with NQDI1 (2 
M). When cells were pretreated with NQDI1,
and the inhibitor was present during priming and activation,
secretion of IL-1 was almost completely abolished in WT
cells. If NQDI1 was present only during the activation step
(ATP), IL-1 secretion from WT cells was diminished com-
pared with untreated cells, but ASK1-deficient cells secreted
significantly less IL-1.
Inflammasome priming and activation were decreased in
bone marrow-derived macrophages from ASK1/ mice. To
determine whether ASK1 deficiency decreased LPS-induced
priming of the inflammasome, we examined the expression of
NLRP3, pro-IL-1, and procaspase-1 by Western blot follow-
ing treatment of BMDMs with LPS. As expected, expression of
NLRP3 and pro-IL-1 increased in WT BMDMs following
LPS treatment (Fig. 4), with the significant increase in NLRP3
and pro-IL-1 occurring within 2 h. In contrast, NLRP3
expression in the ASK1/ BMDMs following LPS stimula-
tion increased after only 4 h. Pro-IL-1 was significantly
increased after 2 h in both WT and ASK1/ cells. Pro-
caspase-1 did not significantly increase in WT or ASK1-
deficient cells as shown in Fig. 4D. To investigate NLRP3
inflammasome activation, cells were treated with LPS (1 h)
followed by ATP. Nigericin treatment was used as a positive
control and for normalization (Fig. 5). The results show that
there was a significant reduction in pro-IL-1, cleaved
caspase-1-p20, and procaspase-1 in ASK1/ BMDMs com-
pared with WT. When WT BMDMs were treated with NQDI1
during the priming and activation steps, there was a significant
decrease in pro-IL-1 (Fig. 5B) compared with untreated WT
cells.
Pharmacological inhibition of ASK1 reduced inflammasome
activation in an alveolar macrophage cell line. To confirm our
results demonstrating that ASK1 promotes inflammasome ac-
tivation, MH-S cells were treated with LPS  ATP in the
presence or absence of the ASK1 inhibitor NQDI1, and pro-
IL-1, IL-1, procaspase-1, and cleaved caspase-1-p20 were
measured by Western blot. ASK1 inhibition caused signifi-
cantly decreased pro-IL-1, cleaved IL-1, and cleaved
caspase-1-p20 (Fig. 6).
DISCUSSION
The NLRP3 inflammasome is an important component in the
progression of ALI (4, 9, 12, 16, 18, 19, 21, 52). Some studies



























































Fig. 3. Apoptosis signal-regulating kinase-1 (ASK1)-
deficient (ASK1/) alveolar macrophages and bone
marrow-derived macrophages (BMDM) secreted less
IL-1 compared with cells from wild-type (WT)
mice in response to lipopolysaccharide (LPS) prim-
ing and ATP activation. A: primary macrophages
were obtained from bronchoalveolar lavage (BAL)
fluid of WT and ASK1/ mice and placed in cul-
ture. Cells were treated with LPS for 1 h followed by
ATP for 30 min. Supernatants were collected, and
IL-1 was measured by ELISA (BD Biosciences kit,
n  3–7). B: BMDMs were exposed to vehicle
control  the ASK1 inhibitor NQDI1 (N) for 1 h, and
then exposed to LPS for 1 h  NQDI1, followed by
ATP for 30 min  NQDI1. Supernatants were col-
lected, and IL-1 was measured by ELISA (n  4;
R&D Systems kit). *Significant difference from WT
(P  0.05).
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tion (19, 21, 23, 25, 27, 28, 52); however, it has also been
demonstrated to play a role in IL-6 production and neutrophil
recruitment independent of IL-1 in murine lung injury models
(36). Both IL-1 and IL-6 are increased in BALF of patients at
risk for or with established ARDS/ALI (1, 2, 17, 34, 35, 39, 41,
45). Additionally, high concentrations of IL-6 may be a prog-
nosticator of poor outcome (1, 24, 26, 33, 34, 48). In the
current study, we demonstrated that ASK1 deficiency reduced
the inflammatory response to LPS in mice, as indicated by
histology, macrophage migration, neutrophil recruitment, and
IL-1 and IL-6 in the BALF. Furthermore, inflammasome
priming and activation were significantly decreased in ASK1-
deficient macrophages and BMDMs and a macrophage cell line
(MH-S) treated with an ASK1 inhibitor. ASK1 has not previ-
ously been identified in inflammasome-mediated signaling or
lung injury.
Alveolar macrophages are the sentinels of innate immunity
in the lung, constantly encountering infectious agents and
particles from the environment (16). Alveolar macrophages
express high levels of PRRs that recognize both pathogen-
associated and damage-associated molecular patterns to alert
the immune system to the presence of a pathogen or stressor
(47). Activation of PRRs results in gene expression of numer-
ous inflammatory mediators. Grailer et al. (12) demonstrated
that activation of NLRP3 is required for development of ALI
using the murine LPS-induced ALI model. In the absence of
NLRP3, there was reduced neutrophil recruitment in the lung,
reduced IL-1 production, and reduced albumin leakage com-
pared with WT LPS-exposed mice. Similarly, other studies
have demonstrated the critical role of the NLRP3 inflam-
masome in LPS-induced and VILI models (12, 18, 19, 21, 27,
28, 52). These studies all point to the important contribution
that NLRP3 makes toward the inflammation characteristic of
ARDS and highlight the need for increased understanding of
the regulation of NLRP3 activation.
We previously demonstrated that mice deficient in ASK1
were protected against VILI in a model with hyperoxia pre-
treatment and subsequent high tidal volume mechanical venti-
lation (34). Fukumoto et al. recently demonstrated that ASK1
was necessary for IL-1 and TNF- production, macrophage
apoptosis, and recruitment of immune cells in the lung follow-
ing exposure to hyperoxia (8). Using systemic administration
of LPS, Matsuzawa et al. (31) showed that ASK1-deficient
mice were resistant to septic shock and that splenocyte pro-
duction of proinflammatory cytokines (including IL-1,
TNF-, and IL-6) was significantly reduced. Other studies
have suggested that ASK1 is an intermediate signal in TLR-
associated innate immune responses (53, 54). However, none
of these studies had linked ASK1 to NLRP3 inflammasome
priming or activation.
Because of the important role of macrophages in host de-
fense, we focused on the role of ASK1 in inflammasome
activity in these cells. Alveolar macrophages are known to be
involved in early inflammatory responses in the lung, including
IL-1 production, and a previous study demonstrated that
exposure of hydrogen peroxide and ATP promoted ASK1/p38-






































































































Fig. 4. Lipopolysaccharide (LPS)-induced priming
of bone marrow-derived macrophages (BMDMs)
was decreased in ASK-1-deficient cells. BMDMs
were isolated and treated with LPS for 2, 4, or 6 h.
A: representative Western blots of NOD-like recep-
tor 3 (NLRP3), pro-IL-1, and procaspase-1 after
LPS treatment of BMDMs. GAPDH was used as a
loading control, and densitometry values were nor-
malized to GAPDH. Each protein indicated was
immunoblotted separately from independent gels,
and each set of bands for a given protein was
cropped from the same blot. Densitometry analysis
is shown for NLRP3 (B), pro-IL-1 (C), and pro-
caspase-1 (D) expression following LPS stimulation
in wild-type and apoptosis signal-regulating kinase-
1-deficient (ASK1/) BMDMs. P  0.05, signifi-
cant difference from wild type (*) and untreated (#)
(n  8–9 for B, 5–7 for C, and 6–7 for D).
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mediated apoptosis of RAW 264.7 macrophage cells (38).
However, inflammasome activity was not investigated in that
study. Although many studies identify macrophage-induced
IL-1 as the delineating step for LPS-induced inflammation
(12, 18, 27, 28), other studies have suggested that LPS-induced
lung injury was dependent on caspase-1 in alveolar macro-
phages (15, 51). In the current study, we demonstrated a
decrease in lung injury in ASK1-deficient mice (Figs. 1 and 2),
and we specifically demonstrated decreased LPS-induced
priming of the NLRP3 inflammasome before the activation
step in ASK1-deficient and ASK1-inhibited cells. LPS-induced
priming of BMDMs was decreased in ASK1-deficient cells
compared with WT cells as indicated by expression of NLRP3
(Fig. 4). Similarly, after stimulation with LPS  ATP to
activate the NLRP3 inflammasome, we found a significant
decrease in secreted IL-1 from ASK1/ macrophages com-
pared with WT cells (Fig. 3). Similarly, LPS  ATP-induced
inflammasome activation stimulated cleavage of caspase-1 and
IL-1 in WT BMDMs, but this was significantly inhibited in
ASK1/ BMDMs (Fig. 5). These results suggest that ASK1
promotes both priming and activation of the NLRP3 inflam-
masome in response to LPS. To further investigate ASK1-
mediated inflammasome signaling, we used the alveolar mac-
rophage cell line MH-S and BMDMs in the presence and
absence of an ASK1 inhibitor, NQDI1. Similar to our results
with ASK1-deficient BMDMs, inhibition of ASK1 caused
decreased cleavage of procaspase-1 and IL-1 in response to
LPS  ATP (Figs. 5 and 6). When NQDI1 was added at the
same time as the ATP (without pretreatment), IL-1 release
from BMDMs was significantly reduced. However, it is pos-
sible that NQDI1 was not present long enough in these exper-
iments to more effectively inhibit ASK1.
There are several limitations in our study. Although we
measured decreased caspase-1 and pro-IL-1 in ASK1-defi-
cient macrophages after NLRP3 inflammasome activation, we
cannot definitively conclude that decreased IL-1 release in
our in vivo model was mediated exclusively through the
NLRP3 inflammasome. Although significantly decreased 3 h
after LPS in vivo, there were no significant decreases in IL-1
at later times. Secretion of IL-1 can occur through multiple
pathways, but previous studies of LPS-induced lung injury
have implicated the NLRP3 inflammasome proteolytic activity
as the key player in IL-1 and caspase-1-associated inflamma-
tory changes (12, 18, 27, 28, 51). The lack of a strong effect on
IL-1 in BAL in our studies, despite significant effects on lung
injury in vivo and on inflammasome signaling in vitro, sug-
gests that IL-1 may also be produced from non-ASK1-
dependent sources and that ASK1 impacts other pathways such
as those involving recruitment of neutrophils and regulation of


























































































































Fig. 5. Inflammasome activation was de-
creased in apoptosis signal-regulating ki-
nase-1 (ASK1)-deficient (ASK1/) bone
marrow-derived macrophages (BMDMs).
Cell lysates were collected from BMDMs
after lipopolysaccharide (LPS) stimulation
for 1 h followed by ATP for 30 min. Pro-IL-
1, procaspase-1, and cleaved caspase-1-p20
were decreased in ASK1/ BMDMs com-
pared with wild type (WT). A and C: repre-
sentative Western blots of pro-IL-1, pro-
caspase-1, and cleaved caspase-1-p20 from
independent experiments. A includes results
from BMDMs pretreated with NQDI1, with
the inhibitor present throughout the experi-
ment. GAPDH was used as a loading control.
Each protein indicated was immunoblotted
separately, and each set of bands for a given
protein was cropped from the same blot.
Unrelated lanes were removed for clarity in A
(break between nigericin-treated and other
samples). Nigericin treatment was used as a
positive control, and all densitometry values
were normalized to GAPDH and then to
nigericin/GAPDH. Densitometry analysis of
pro-IL-1 (B), procaspase-1 (D), and cleaved
caspase-1-p20 (E) expression is shown. *Sig-
nificant difference compared with WT (P 
0.05; n  4).
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ASK1 phosphorylation during inflammasome priming and ac-
tivation, and we do not know which downstream mitogen-
activated protein kinase mediators are necessary for regulation
of the NLRP3 inflammasome. Previous studies have suggested
that IL-1 production is dependent on p38 activation in mac-
rophages and other tissues (13, 25, 37, 38), and JNK has been
reported to be an upstream regulator of the phosphorylation of
ASC (14). Recent evidence also suggests that ERK can poten-
tiate NLRP3 priming (10). We previously demonstrated that a
combined hyperoxia/VILI was dependent on JNK-mediated
signaling (29), but we did not previously link that to ASK1
activation. We are currently investigating these pathways.
Another limitation is that our isolation of alveolar macrophages
may have included a small population of nonmacrophage cells
that could potentially affect the response. When we used F4/80
staining to identify macrophages, we found that 	98% of the
cells were positive for this marker. Despite the limitations
described here, the use of both ASK1-deficient cells and a
pharmacological inhibitor strongly supports the role of ASK1
in inflammasome priming and activation.
In summary, we have identified ASK1 as a key regulator of
NLRP3 inflammasome priming and activation in response to
LPS-induced lung injury. Targeting an upstream regulator of
inflammasome activation that has also been linked to apoptosis
and fibrosis of the lung may provide a novel therapeutic
strategy for the prevention of cellular injury during infectious
and/or VILI. The role of ASK1 at the intersection between
apoptosis and inflammation could lead to an approach for
minimizing the prolonged inflammatory effect seen in ARDS.
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Fig. 6. Pharmacological inhibition of apoptosis signal-regulating kinase-1 (ASK1) reduced inflammasome activity in MH-S cells. MH-S cells were treated with
lipopolysaccharide (LPS) for 1 h followed by ATP for 30 min in the presence or absence of the ASK1 inhibitor NQDI1, and cell lysates were collected. A:
representative Western blots of pro-IL-1, IL-1, procaspase-1, and cleaved caspase-1-p20. GAPDH was used as a loading control. Nigericin treatment was used
as a positive control. Each protein indicated was immunoblotted separately, and each set of bands for a given protein was cropped from the same blot. Unrelated
lanes were removed for clarity. Densitometry analysis of pro-IL-1 (B), IL-1 (C), procaspase-1 (D), and cleaved caspase-1-p20 (E) expression is shown.
Densitometry values were first normalized to GAPDH and then to the level of the corresponding protein for nigericin-treated cells. *Significant difference
compared with wild type (P  0.05; n  3–6).
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